These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30475266)

  • 1. HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection.
    Cysique LA; Jugé L; Lennon MJ; Gates TM; Jones SP; Lovelace MD; Rae CD; Johnson TP; Nath A; Brew BJ
    AIDS; 2019 Mar; 33(3):433-441. PubMed ID: 30475266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.
    Cysique LA; Moffat K; Moore DM; Lane TA; Davies NW; Carr A; Brew BJ; Rae C
    PLoS One; 2013; 8(4):e61738. PubMed ID: 23620788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.
    Cysique LA; Jugé L; Gates T; Tobia M; Moffat K; Brew BJ; Rae C
    Neurol Neuroimmunol Neuroinflamm; 2018 Jan; 5(1):e430. PubMed ID: 29312999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
    Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
    AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.
    Anderson AM; Fennema-Notestine C; Umlauf A; Taylor MJ; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Letendre SL;
    J Neurovirol; 2015 Oct; 21(5):559-67. PubMed ID: 26069183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
    Gongvatana A; Harezlak J; Buchthal S; Daar E; Schifitto G; Campbell T; Taylor M; Singer E; Algers J; Zhong J; Brown M; McMahon D; So YT; Mi D; Heaton R; Robertson K; Yiannoutsos C; Cohen RA; Navia B;
    J Neurovirol; 2013 Jun; 19(3):209-18. PubMed ID: 23613008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.
    Mohamed MA; Barker PB; Skolasky RL; Selnes OA; Moxley RT; Pomper MG; Sacktor NC
    Magn Reson Imaging; 2010 Nov; 28(9):1251-7. PubMed ID: 20688449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
    Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.
    Harezlak J; Buchthal S; Taylor M; Schifitto G; Zhong J; Daar E; Alger J; Singer E; Campbell T; Yiannoutsos C; Cohen R; Navia B;
    AIDS; 2011 Mar; 25(5):625-33. PubMed ID: 21297425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.
    Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ
    AIDS; 2019 Oct; 33(12):1843-1852. PubMed ID: 31274535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
    Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P; Robertson K; Hagberg L; Zetterberg H; Gisslén M; Spudich S
    J Infect Dis; 2013 Jun; 207(11):1703-12. PubMed ID: 23460748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter damage, neuroinflammation, and neuronal integrity in HAND.
    Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
    J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
    Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
    BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
    Edén A; Marcotte TD; Heaton RK; Nilsson S; Zetterberg H; Fuchs D; Franklin D; Price RW; Grant I; Letendre SL; Gisslén M
    PLoS One; 2016; 11(6):e0157160. PubMed ID: 27295036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    Yiannoutsos CT; Nakas CT; Navia BA;
    Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
    Peluso MJ; Valcour V; Ananworanich J; Sithinamsuwan P; Chalermchai T; Fletcher JL; Lerdlum S; Chomchey N; Slike B; Sailasuta N; Gisslén M; Zetterberg H; Spudich S;
    J Infect Dis; 2015 Dec; 212(11):1759-67. PubMed ID: 25995196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.